Abstract
Natural hydrogels are promising scaffolds to engineer epidermis. Currently, natural hydrogels used to support epidermal regeneration are mainly collagen- or gelatin-based, which mimic the natural dermal extracellular matrix (ECM) but often suffer from insufficient and uncontrollable mechanical and degradation properties. In this study, a photocrosslinkable gelatin (i.e., gelatin methacrylamide (GelMA)) with tunable mechanical, degradation and biological properties is used to engineer the epidermis for skin tissue engineering applications. The results reveal that the mechanical and degradation properties of the developed hydrogels can be readily modified by varying the hydrogel concentration, with elastic and compressive moduli tuned from a few kPa to a few hundred kPa and the degradation times varied from a few days to several months. Additionally, hydrogels of all concentrations displayed excellent cell viability (>90%) with increasing cell adhesion and proliferation with increase in hydrogel concentrations. Furthermore, the hydrogels are found to support keratinocyte growth, differentiation and stratification into a reconstructed multi-layered epidermis with adequate barrier functions. The robust and tuneable properties of GelMA hydrogels have suggested that the keratinocyte laden hydrogels can be used as epidermal substitutes, wound dressings or substrates to construct various in vitro skin models.
Keywords: photocrosslinkabe gelatin, epidermis, mechanical properties, degradation, keratinocytes
1. Introduction
Healing of cutaneous wounds involves regeneration of surface epidermis and repair of connective tissues. Re-epithelialization precedes repair in the dermis and accelerates the process of wound healing.[1, 2] It also provides early re-establishment of a functional barrier, which is vital in the prevention of excessive transepidermal water loss and infection.[3] Therefore, re-epithelialization is considered a primary step in cutaneous wound healing.[2]
Various types of tissue engineered scaffolds have been developed and used for engineering epidermis.[4] Ideally, these scaffolds should exhibit certain biological features (i.e. to support keratinocyte adhesion, proliferation and differentiation) and possess appropriate mechanical and degradation properties.[5] Mechanical properties of the scaffolds have been identified as a key modulator in keratinocyte behavior with increased cell adhesion and proliferation on stiffer substrates with compressive moduli of around 100 kPa.[6] The scaffolds should also be sufficiently strong and elastic for facile handling during surgery[7] and for supporting natural movements of the tissues.[8] Additionally, such scaffolds should ideally degrade only after adequate healing, which could take more than 8 weeks.[9] Furthermore, for some clinical applications, the scaffolds are required to be rapidly crosslinked in situ, allowing for optimal molding towards the wound contour.[10]
Based on these requirements, natural hydrogels are considered as attractive candidates to engineer epidermis due to their unique combination of biological and physical properties including biocompatibility as they mimic extracellular matrix (ECM), adjustable mechanical, swelling and degradation properties, as well as in situ crosslinking capabilities.[11, 12] Amongst natural hydrogels, collagen is highly popular as collagen is the major component of the basement membrane on which the epidermis sits, thereby supporting keratinocyte proliferation, migration and differentiation.[13, 14] However, some of the limitations of collagen hydrogels for epidermis regeneration include their low mechanical properties and fast degradation rate.[15] These challenges could be tackled by varying collagen concentrations (which may lead to heterogeneity of hydrogels)[16, 17] or by plastic compression (which needs post-processing of hydrogels).[18, 19] Additionally, higher mechanical strength and slower degradation rates could be achieved at the expense of elasticity as demonstrated by Awang et al. resulting in a stronger but brittle scaffold.[20] Other weaknesses of collagen include potential toxicities caused by chemical cross-linking agents (e.g. glutaraldehyde) that are generally employed to improve mechanical properties and stability.[21] Therefore, the currently developed collagen hydrogels remain sub-optimal as scaffolds for skin substitutes.
As an alternative to collagen, gelatin (i.e. hydrolyzed collagen) has attracted increasing attention as it has relatively low antigenicity compared to collagen whilst maintaining the properties of biocompatibility and biodegradability, in addition to being significantly less expensive than collagen.[21] Modification of gelatin with photocrosslinkable methacrylamide groups (GelMA) maintains the unique properties of gelatin, but additionally endows the material to be solidified from liquid to solid permanently via chemical reaction of the methacrylamide groups.[22] The hydrogel prepolymer solution can be spread on the wound area of different shapes and rapidly crosslinked in situ towards the wound contour upon light exposure. By selecting proper photo-initiators (PIs, e.g. Irgacure 2959), high crosslinking degree of polymer can be achieved within minutes or even seconds at low concentration of PIs, minimizing cytotoxicity.[23] In addition, the transparent nature of crosslinked GelMA allows for easy observation of cellular behaviour encapsulated within or seeded onto the hydrogel. Furthermore, by varying the methacrylation degree, GelMA concentration or photo-polymerization time (i.e. to change the polymer crosslinking density for controlling the hydrogel network structure), its mechanical, degradation and biological properties can be easily tuned.[22, 24] Such control of the hydrogel network structure endows the scaffolds with the proper design and characteristics of the physical and biological properties. Hence the mechanical, degradation and biological properties of the GelMA hydrogels can be varied in a controlled manner and with relative eases to allow for applications as skin substitutes at different body sites and for different wound types. Application of GelMA hydrogels in tissue engineering (e.g., blood vessel regeneration) has been published previously.[22, 24] The present study focuses on a novel application of GelMA hydrogel in tissue engineering – skin regeneration which needs stiffer and stronger surfaces to support keratinocyte adhesion and proliferation[6] and significant prolonged degradation profiles as cutaneous wounds frequently heal over longer periods of time of up to 8 weeks.[9]
In this paper, GelMA hydrogels with varying concentrations were synthesized for epidermal reconstruction. The physical properties of the hydrogels were fine-tuned by systematically varying GelMA concentrations to control keratinocyte adhesion, proliferation and differentiation. Finally, a confluent keratinocyte monolayer was developed and reconstruction of stratified and functional epidermis was achieved using the hydrogel scaffolds.
2. Results and Discussion
2.1. Physical Properties of GelMA Hydrogels
The synthesized GelMA was found to have a degree of methacrylation around 75%, consistent with previous report (data not shown).[25] Upon UV exposure, the prepolymer solution of GelMA could form a crosslinked network (Figure S1A, Supporting Information). It was found that at all concentrations of GelMA ranging from 5% to 20%, the gel precursor solution could be injected via a conventional 27- gauge needle into a PDMS mold to form hydrogels of various shapes (round, square, star and triangle) after UV polymerization (Figure S1B, Supporting Information).
Firstly, we characterized the scaffold's mechanical properties as these are important parameters for engineering optimal skin substitutes. Compressive stress-strain curves illustrated a positive correlation between GelMA concentrations and compressive moduli, ranging from less than 5 kPa (5% GelMA) to ~110 kPa (20% GelMA) (p<0.05, Figure 1A and B), likely due to an increased crosslinking density at higher GelMA concentrations. High compressive moduli (~100 kPa) have previously been demonstrated to be favorable for keratinocyte growth.[6]
Tensile stress-strain curves followed a similar trend with increased GelMA concentrations resulting in higher elastic moduli and ultimate strength (p<0.05) (Figure 1C). 20% GelMA hydrogels were found to have elastic moduli of up to 200 kPa and ultimate strengths of 30 kPa. Such high values are beneficial considering the significant amount of stretching and bending forces exerted during wound healing.[26] Although higher GelMA concentrations correlated with reduced elongation at break points from 40% (5% GelMA) to 20% (20% GelMA) possibly due to the increased crosslinking density limiting hydrogel deformation, the 20% extensibility may still be considered appropriate for skin substitutes.[8] In summary, robust yet tunable mechanical properties of GelMA hydrogels make them ideal candidates as substitute materials for skin regeneration as their properties can mirror the broad range of elasticity found in native skin.[8]
We further characterized the hydrogel's swelling ratio which indicates water sorption capacity thus predicting the rate of hydrogel degradation.[27] It was found that increasing GelMA concentrations from 5% to 20% resulted in reduced swelling ratios from 1500% to 500% (p<0.05) (Figure 1E), likely due to increased crosslinking densities at 20% GelMA. This not only limits the rate and amount of water penetration but is also thought to slow down degradation.[28]
To evaluate degradation, GelMA hydrogels were incubated in collagenase solution. As shown in Figure 1F-G, the degradation rate decreased with increasing GelMA concentrations, with complete degradation by less than 3 days (5% GelMA) to upwards of 8 weeks (20% GelMA). Interestingly, 20% GelMA hydrogels remained present even after 8 weeks of incubation, albeit at significantly reduced size which may be attributable to increased methacrylamide crosslinks in 20% GelMA which are resistant to collagenase. Compared to previously developed collagen hydrogels which usually last for only 1 month,[16, 17] GelMA hydrogels are thought to be better suited for long-term wound healing cases by remaining in the wound bed long-term,[9] thus ensuring optimal healing whilst avoiding secondary infections.
The above results have suggested that the mechanical and degradation properties of GelMA hydrogels can be readily tuned to a great extent by varying GelMA concentrations. Compressive and elastic moduli could be tuned from a few kPa to a few hundred kPa and the degradation times could be varied from a few days to several months (Table 1), indicating the hydrogel's broad spectrum of properties as skin substitutes in different body sites and for different wound types.
Table 1.
GelMA concentration (%) | Compressive modulus (kPa) | Tensile modulus (kPa) | Tensile strength (kPa) | Elongation at break (%) | Swelling ratio (%) | Degradation (%) |
||
---|---|---|---|---|---|---|---|---|
3 days | 7 days | 56 days | ||||||
5 | 3±1 | 9±1 | 4±1 | 40±6 | 1476±28 | 100 | 100 | 100 |
7.5 | 14±2 | 17±2 | 7±1 | 39±5 | 1273±26 | 80±5 | 100 | 100 |
10 | 26±3 | 57±9 | 18±1 | 34±5 | 719±24 | 30±2 | 65±3 | 100 |
15 | 89±9 | 153±18 | 24±2 | 27±5 | 567±19 | 20±3 | 35±4 | 100 |
20 | 108±8 | 194±16 | 29±3 | 22±4 | 470±9 | 8±1 | 24±4 | 80±7 |
2.2. Cell Viability, Adhesion and Proliferation on GelMA Hydrogels
2.2.1 Cell viability
The ability of cells to attach, spread and grow on hydrogels is of fundamental importance for tissue development.[29-33] We evaluated keratinocytes viability by quantifying the live and dead cells adhered on the surfaces of hydrogels made from different concentrations of GelMA. Immortalized human keratinocytes (HaCaTs) were used in this study as application of HaCaTs in epidermal tissue regeneration through cell culture, wound healing and transplantation studies is well documented.34-36] Cell viabilities were found higher than 90% at 1, 4 and 7 days for all GelMA concentrations (Figure 2A and C), demonstrating the innate biocompatibility of GelMA hydrogels.
2.2.2. Cell adhesion and proliferation
Investigation of the area of hydrogels covered by HaCaTs indicating cell attachment and the number of cells on the surfaces of GelMA over time indicating cell proliferation revealed that increasing the concentration of GelMA resulted in statistically significant increase in cellular attachment (Figure 2B and D, p<0.05) and proliferation (Figure 2 B and E, p<0.05). This suggested that stiffer hydrogels and/or increased cell binding sequences (Arg-Gly-Asp (RGD)) may promote cellular attachment on the hydrogels.[6] Overall, these results illustrated that HaCaT cells could proliferate on all GelMA hydrogels over a period of 7 days and that increasing the GelMA concentration could increase HaCaT attachment and proliferation.
Keratinocytes have to establish a confluent monolayer prior to developing a stratified epidermal layer.[37] On a macroscopic level, HaCaT cells were shown to proliferate and form a confluent layer after being submerged in culture media for 7 days or longer depending on GelMA concentrations, resulting in the formation of a transparent GelMA hydrogel (Figure S2A, Supporting Information), covered with a thin white cell sheet as shown in Figure S2B, Supporting Information. We further demonstrated that cells cultured on 20% GelMA hydrogels formed a confluent monolayer after 7 days of submerged culture as indicated by light microscopic images (see example in Figure 2Fi) and presence of prominent fluorescence of E-cadherin (Figure 2Fii), a cell-junction protein. The development of a confluent monolayer is vital for subsequent homogeneous epidermal stratification as non-uniform and patchy keratinocyte colony formation may result in some highly stratified areas sloughing off whilst other areas were only beginning to stratify.[38] As the 20% GelMA with increased methacrylamide crosslinks exhibited optimal compressive modulus (~ 110 kPa) to support the keratinocyte adhesion and proliferation, these scaffolds were selected in the following study to reconstruct epidermis.
2.3. In Vitro Epidermal Development on GelMA Hydrogels
After a monolayer of HaCaT cells was developed, the constructs were lifted to air-liquid interface (ALI) to induce HaCaT differentiation and stratification. Macroscopically, lifting the construct to the ALI for 2 weeks resulted in the formation of a cell multi-layer (Figure S2C, Supporting Information), which became thicker in week 6 under ALI conditions (Figure S2D, Supporting Information). Haematoxylin and eosin (H & E) stained images revealed that HaCaTs stratified and flattened on both GelMA (Figure 3A) and control collagen (Figure 3B) hydrogel surfaces after culture at ALI for 6 weeks. Basal keratinocytes showed columnar morphology whereas the keratinocytes further away from the constructs exhibited flattened morphology. With significant increase in thickness over time (p<0.05), the developed epidermis was approximately 20 μm, 50 μm and 100 μm after 2, 4 and 6 weeks, respectively, of ALI culture on both GelMA hydrogels and control collagen scaffolds (compare Figure 3Ai and ii, B i and ii). There was no significant difference in thickness between the epidermis grown on GelMA or collagen (p>0.05). The engineered epidermis on either scaffold was thinner compared to the sample of human abdomen epidermis (120 μm) (Figure 3C and D), but still within the range of native human epidermis (75 ~150 μm).[13] It is noteworthy that after 6 weeks of ALI culture, GelMA hydrogels were still present as opposed to collagen scaffolds which almost disappeared, indicating long-term substrate stability using the 20% GelMA hydrogels.
Protein expression analysis of the reconstructed epidermis on GelMA (Figure 4A) or control collagen (Figure 4B) hydrogels demonstrated the appearance of both ki67 (proliferation marker) and involucrin (terminal differentiation marker, expressed in the suprabasal layers of stratified squamous epithelium) after 6 weeks of ALI culture. The reconstructed epidermis exhibited slightly disorganized structure possibly due to the immature terminal differentiation of HaCaT cells[34, 39] or to the absence of paracrine signalling from fibroblasts during culture,[34-37, 40] which may be normalized when cultured in vivo.[36] With significant increase over time, the developed epidermis had 4, 6 and 10 layers after 2, 4 and 6 weeks, respectively, of ALI culture on either GelMA or collagen surfaces. Quantification of the layers of reconstructed epidermis showed no significant difference between the two substrates and their thickness was comparable with the normal human epidermis consisting of 8-12 keratinocyte layers (Figure 4C and D).[42]
2.4. Barrier Formation of Reconstructed Epidermis
Electrical resistance measurements provide an indication of skin's barrier integrity and thus its relative hydration values.[43] Statistical analysis demonstrated significant differences between the relative resistances of collagen scaffolds, collagen scaffolds with reconstructed epidermis (epidermis (C)), GelMA hydrogels (20%), and GelMA hydrogels with reconstructed epidermis (epidermis (G)) (p<0.05) (Figure 5A). Collagen scaffolds lacking an epidermis displayed least resistance at ~700 Ω which was more than twice lower compared to the resistance of the corresponding GelMA hydrogels (p<0.05). Barrier function of both scaffolds was predictably increased by the reconstructed epidermal layer compared to the cell-free substrates where the resistance of the epidermis (C) increased two-fold from 700 Ω to ~ 1400 Ω (700 Ω increase) and that of epidermis (G) from 1700 Ω to 2600 Ω (900 Ω increase) when compared to their cell-free equivalents. These results primarily indicated that the collagen scaffold had an inherently lower barrier integrity compared to GelMA hydrogels possibly due to high levels of crosslinking of the latter and lower water content,[44] and secondly that the addition of an epidermal layer successfully increased barrier properties probably due to functional tight junctions and a stratified architecture of confluent keratinocytes.[45, 46] The resistance values of the reconstructed epidermis were smaller than that of human skin (1,000-10,000 ohm) possibly due to less degree of stratifications resulting from immature terminal differentiation of HaCaT cells[34, 39] or absence of paracrine signalling from fibroblasts during culture,[34-37, 39] which may be normalized when cultured in vivo.[41]
A tissue engineered skin substitute should ideally be able to control water loss from a wound bed[47] to prevent excessive dehydration as well as the build-up of exudates.[48] As expected, scaffolds without an epidermal cover, had significantly higher rates of water loss per day compared to those with an epidermis (p<0.05) (Figure 5B). Collagen scaffolds had the lowest ability to retain water with loss rates approaching 3 g m−2 day−1 which was almost twice the amount lost by GelMA hydrogels, possibly due to the higher crosslinking density of GelMA which improved physical water retention. The addition of an epidermal layer significantly reduced water loss for both collagen and GelMA scaffolds with water loss rates being almost identical at around 1 g m−2 day−1, less than the trans-epidermal water loss of normal human skin (~4 g m−2 day−1), possibly due to the lack of presence of sweat glands.[45] Interestingly, no difference could be observed between the collagen scaffolds layered with an epidermis and naked GelMA, indicative of a synergistic barrier function between GelMA hydrogels and the epidermis. These results indicated the significant protective barrier function for GelMA based reconstructed epidermis exerted by both the crosslinking and the epidermal cover. This is important as dehydration remains as the major complications of untreated severe skin losses due to extreme trans-epidermal water loss.[50]
Regenerated skin not only has to prevent loss of water from within the body but also functions as a relative barrier to harmful external insults. To evaluate the resistance of the reconstructed epidermis to external moisture, we studied the permeability of the scaffolds covered with epidermis and their cell-free counterparts to dextran solution. Dextran diffusion studies exhibited highest permeability at almost 100% for naked collagen scaffolds and lowest at 80% after 2 h of diffusion for epidermis (G) (Figure 5C). No difference was observed between epidermis (C) and the naked GelMA, corroborating the results obtained with water loss studies (see above). These results, again, highlighted the importance of both the presence of crosslinked networks and the epidermal cover in preventing diffusion of water molecules either way across the skin. The above results have demonstrated that the reconstructed epidermis had increased resistance and decreased trans-epidermal water permeability, indicative of improved barrier functions.
Our work demonstrates a simple, cost-effective technique to reconstruct functional epidermis using a hydrogel based on photocrosslinkable GelMA with robust mechanical, degradation and biological properties. These hydrogels were able to support the development of multi-layered, renewable keratinocytes with similar organization and differentiation as human epidermis. Changes in GelMA concentration would provide the means to fine-tune its physical and biological properties in order to meet specific requirements as skin substitutes in different body sites and for different wound types.[51] Moreover, since GelMA is light-polymerizable, it could be easily molded or micropatterned into various shapes and configurations upon light exposure for a broad spectrum of tissue engineering applications.[22] In terms of skin regeneration, photocrosslinkable hydrogels may be particularly useful in the treatment of trauma wounds which are frequently extensive and irregular. Wound beds of any shape may easily and homogenously be filled using liquid uncrosslinked hydrogel precursors. Upon light exposure, photocrosslinking can thus enable solidification of the precursor. Alternatively, light-polymerizable GelMA could be applied to the regeneration of palmoplantar epidermis with ridges and the interphase between palmoplantar and normal hairy skin, where a gradient in epidermis thickness exists. Furthermore, the hydrogel nature endows GelMA with ready modification of its chemical and physical properties (e.g., incorporation or conjugation of different growth factors). The unique combination of photo-polymerizability, optimal mechanical properties, biodegradability and biocompatibility make GelMA a promising material for skin tissue engineering.[22] Such exceptional characteristic of GelMA also distinct them from other reported substrates to reconstruct epidermis including polycarbonate membrane[52] or decellularized porcine intestine[53] which cannot be tailor made according to the patient's own wounds and whose physical and chemical properties cannot be readily modified. We anticipate that the developed GelMA hydrogel could find applications as epidermal substitutes, wound dressings or substrate to construct in vitro skin models. Future work will include the evaluation of fibroblasts within the dermal layer towards commercialization of this skin equivalent.
3. Conclusion
In this study, we have synthesized photocrosslinkable GelMA hydrogels with tunable mechanical and degradation features ideally suited as skin tissue engineering scaffolds. We have found that by varying the concentration of GelMA prepolymer solution, the physical and biological properties of the resultant hydrogels could be adequately controlled to meet the requirements for epidermis formation. Hydrogels of higher concentrations displayed improved material stiffness for cell adhesion and keratinocyte monolayer formation, combined with sufficiently prolonged resistance to collagenase degradation. GelMA hydrogels supported the formation of a stratified epidermis with certain barrier function (e.g. electrical resistance and prevention of water loss). The authors envision that the developed GelMA hydrogels can find applications as epidermal substitutes, wound dressings or substrates to construct in vitro skin models.
4. Experimental Section
Synthesis of GelMA
Synthesis of GelMA was described previously.[54] Briefly, 10.0 g of type A porcine skin gelatin (Sigma-aldrich, St. Louis, MO) was added into 100 mL of Dulbecco's phosphate-buffered saline (DPBS) (Invitrogen, San Diego, CA) and dissolved by stirring at 60°C using magnetic stirrer. 8.0 mL of methacrylic anhydride was then added to react with the gelatin solution under vigorous stirring for 3 h at 50°C. Then, the reaction was stopped by a 5-fold dilution of the polymer solution with warm (40°C) DPBS. Salts and unreacted methacrylic anhydride were removed from the mixture by 1-week dialysis with 12-14 kDa cut-off in distilled water at 40°C. White porous foam was then obtained by lyophilizing the solution for 1 week and was store at −80°C until further use. The degree of methacrylation was defined as the ratio of the number of methacrylamide groups tagged to gelatin to the number of amine groups in unreacted gelatin. Using 1H NMR (Varian Inova 500), such value was obtained by the integration of peaks at 7.4 ppm corresponding to the aromatic residues of gelatin, and peaks at 5.5 ppm and 5.7 ppm corresponding to methacrylamide groups.[25]
Preparation of GelMA Hydrogels
Varying amounts of freeze-dried GelMA macromer was dissolved in DPBS containing 0.5% (w/v) 2-hydroxy-1-(4-(hydroxyethoxy)phenyl)-2-methyl-1-propanone (Irgacure 2959, CIBA Chemicals, Basel, Switzerland) as photoinitiator at 80°C to make final GelMA concentrations at 5%, 7.5%, 10%, 15%, and 20% (w/v). The prepolymer solution was then pipetted into a polydimethylsiloxane (PDMS) mold, covered with 3- (Trimethoxysilyl) propyl methacrylate (TMSPMA)-treated glass slide and exposed to 6.9 mW cm−2 UV light (360–480 nm) for a certain period of time. For compression test, swelling ratio and degradation study, samples of 6 mm diameter and 3 mm thickness were fabricated upon 180 s of UV exposures whereas for tensile test, samples of 11 mm length, 5.5 mm width and 1 mm thickness were fabricated using 60 s of UV exposures. For biological studies, samples of 6 mm diameter and 150 μm thickness were produced upon 20 s of UV exposure. The UV time for curing samples of different thickness was optimized to allow sufficient crosslinking of GelMA prepolymer solution of various concentrations. The sample thickness of 150 μm for biological studies was selected in present study to allow better epidermis reconstruction and easy handling. Preliminary results have shown that samples with thickness over 200 μm resulted in slightly disorganized multi-layered epidermis (see Figure S3 in supplementary information) where the basal keratinocytes did not exhibit columnar morphology although the keratinocytes further away from the constructs exhibited flattened morphology. This may be due to the insufficient nutrient transport at ALI during culture. In addition, when the thickness of GelMA hydrogel was less than 100 μm, handling of the resultant hydrogel became difficult (e.g., placing the hydrogel on the cell inserts). For all tests, 5 replicates were used unless otherwise stated.
Characterization of Physical Properties of GelMA Hydrogels
A. Compression Test
Crosslinked samples were detached from the glass slide and incubated in DPBS at 37°C for 24 h. The samples were then blotted dry and compressed at a rate of 1 mm min−1 using an Instron 5542 mechanical tester. The compressive modulus was calculated as the slope in the linear region of the stress-strain curve corresponding to 0 –10% strain.[55]
B. Tensile Test
Samples were incubated in DPBS at 37°C for 24 h, and then blotted dry and fixed by two clamps of Instron 5542 mechanical tester. The samples were stretched at a constant rate of 1 mm min−1 at room temperature. The elastic modulus was determined as the slope in the linear region of the stress-strain curves corresponding to 0–10% strain.[55]
C. Swelling Ratio Analysis
Samples were incubated in DPBS at 37°C for 24 h, taken from DPBS, lightly blotted dry and weighed (WS). Samples were then freeze-dried and weighed to determine the dry weight (WD). The swelling ratio of the swollen gel (SR) was calculated according to Equation (1):[56]
(1) |
D. Degradation Study
Samples were placed in 1.5 ml Eppendorf tubes with 500 μL of DPBS with 2 U mL−1 of collagenase type II at 37°C continuously for 3 weeks, then replaced with 500 μL of DPBS with 0.2 U mL−1 of collagenase for 5 weeks, which corresponds to the collagenase concentration during wound healing.[57] The collagenase solution was refreshed every 2-3 days to maintain constant enzyme activity. At predetermined time points, the collagenase solution was removed and the samples were washed with sterile deionized water two times, freeze-dried and weighed. Morphology of the samples at different time points was also recorded. The percentage degradation (D%) of the gels was determined using Equation (2):
(2) |
where W0 is the initial sample dry weight and Wt is the dry weight after time t.
Development of HaCaT Monolayer
A. Culture of HaCaTs
HaCaTs were obtained from German Cancer Research Center (DKFZ) (Heidelberg, Germany) and maintained as previously described.[58] Briefly, cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM, Invitrogen, San Diego) supplemented with 10% fetal bovine serum (FBS) (Life Technologies, NY) and 1% penicillin/streptomycin (Life Technologies, NY) at 37°C and 5% CO2. Cells were maintained in tissue culture polystyrene and passaged at 1:6 when the cells reached 70% confluency.
B. Cell Viability
HaCaT cell suspension was seeded on the surface of samples with different GelMA concentrations at a seeding density of 5×104 cells cm−2. A calcein AM/ethidium homodimer-1 live/dead® assay (Life Technologies, NY) was performed according to the manufacturer's instructions to examine the cell viability on the GelMA hydrogels following 1, 4 and 7 days of culture in medium.[59] To stain the cells, medium was replaced with 300 μL of live/dead® dye solution (0.5 μL of calcein AM and 2 μL of ethidium homodimer per 1 mL DPBS) for 15 min in the dark at 37°C. The cells were then imaged using a Nikon Eclipse Ti-S fluorescence microscope. Total number of live and dead cells was quantified using NIH ImageJ software and the cell viability was determined as the ratio of live cells relative to the total cell number.
C. Cell Adhesion and Proliferation
Rhodamine-labeled phalloidin (Alexa Fluor 594, Life Technologies, NY) and DAPI (Sigma, St Louis, MO) were used for F-actin and cell nuclei staining respectively according to the manufacturer's instructions to examine cell adhesion on samples following 1, 4, and 7 days of culture in medium. Briefly, following 3× PBS wash, samples were fixed in 4% paraformaldehyde (PFA) for 30 min, permeabilized using 0.1% Triton X-100 for 20 min, then blocked in 1% BSA for 45 min. Rhodamine-labeled phalloidin solution (dilution 1:40) was then added and incubated with the cells at 37 °C for 45 min. Lastly, DAPI solution (dilution 1:1000) was added to the cells and incubated at 37°C for 5 min. The cells were then imaged using Nikon fluorescence microscope and the cell number and cell area were measured using NIH ImageJ software.[60]
D. Tight Junction Formation Analysis
To characterize the formation of a cell monolayer, after fixation, permeabilization and blocking, the samples were stained with an E-Cadherin antibody (a cell adhesion molecule and epithelial cell marker) diluted 1:200 in PBS containing 1% BSA for 45 min at room temperature. Samples were subsequently incubated with FITC-labelled goat-anti-mouse secondary antibody (dilution 1:800, Life Technologies, NY) for 45 min in dark and then incubated with DAPI solution (dilution 1:1000) at 37°C for 5 min. The cells were then imaged using Nikon fluorescence microscope and the cell number and cell area were measured using NIH ImageJ software.
Reconstruction and Analysis of Epidermis
A. Epidermal Differentiation at ALI
To reconstruct epidermis, the hydrogel samples were placed into cell inserts with 6.5 mm diameter and 0.4 μm pore polycarbonate membrane (Corning® Transwell®-24 well permeable supports, Sigma-Aldrich, WI) and then seeded with HaCaTs at a density of 5×104 cells cm−2. 1 mL of HaCaT growth medium was added to each well in order to get submerged culture condition. Medium was changed on a daily basis. Collagen hydrogels were fabricated according to manufacturer's instruction (Life Technologies, NY) and used as controls. Briefly, collagen (5mg mL−1), sterile 10X PBS, 1 mol L−1 NaOH and sterile distilled water were mixed at the ratio of 8/1/0.2/0.8. 10 μL of the mixture was then added into the cell inserts and incubated at 37°C for 40 min. The gels were rinsed by cell culture medium prior to cell seeding.
After one week of submerged culture, cells were lifted to ALI to induce differentiation. The differentiation medium used was DMEM/F12 (3:1, v/v) supplemented with 10% FBS, 1% penicillin/streptomycin, 1.8 mmol L−1 Ca2+, 5 μg mL−1 Insulin, 0.4 μg mL−1 Hydrocortisone, 20−12 mol L−1 Triiodothyronine, 0.18 mmol L−1 Adenine, 5 μg mL−1 Transferrin, 2 ng mL−1 Transforming growth factor - α (TGF-α) and 100 ng mL−1 granulocyte-macrophage colony-stimulating factor (GMCSF).[36, 61, 62] TGF-α and GMCSF were used to facilitate the formation of a stratified epithelium with more comparable structures to the cultures of primary human keratinocytes.[36] 360 μL of differentiation medium was used to maintain the ALI. Cells remained at the ALI for 6 weeks with regular changes of differentiation medium twice a day.
B. Histology Analysis
To view the stratified multilayer of resultant epidermal layer, samples (cultured at 2, 4 and 6 weeks after ALI) were fixed in 4% PFA for 30 min and washed 3× by DPBS. The samples were cryoprotected first in 15% sucrose solution for 4 h and then in 30% sucrose solution for another 4 h at room temperature. The fixed samples were then mounted using OCT compound (Fisher Scientific, MA) in Tissue-Tek Crymold (Sakura Finetek USA, Inc. Torrance, CA), frozen using a mixture of 100% ethanol and dry ice and stored at −80°C prior to sectioning. Sections of 5 μm thickness were cut using a cryostat (Leica CM 3050; Leica Microsystems, Wetzlar, Germany) at −20°C, collected on Superfrost® microscope slides (Fisher Scientific, MA).
Paraffin-embedded human abdominal skin excisions (from 39 year old female, Caucasian) was used as control in this study and was received from Drs. Chong-Hyun Won and Thanh-Nga Tran from the Cutaneous Biology Research Center at Massachusetts General Hospital under a protocol approved by the institutional review board.[58] The samples were cut at 5 μm using a Reichert-Jung 2035 microtome prior to staining with H&E.
The section-mounted glass slides were immersed into a hematoxylin solution (Leica biosystems, IL) for 5 min, washed with tap water for 1 min and dipped in 1% acid alcohol twice. It was further immersed in Bluing solution for 2 min and then in an eosin Y solution (Sigma Aldrich, WI) for 20 s. After washing with tap water for 1 min, the glass slides were sequentially immersed in a series of ethanol solutions (70%, 95%, 100% 2×), 2 min each for dehydration. After immersion in xylene for 3 min twice, the labeled glass slides were sealed with a coverslip using Permount™ Mounting Medium (Fisher Scientific, MA). Visualization of samples was performed using a Nikon microscope with infinicam.
C. Protein Expression of Developed Epidermis
Differentiation of HaCaTs was assessed by monitoring the expression of involucrin, (differentiation marker) and ki-67 (a proliferation marker). The sectioned samples were first permeabilized in 0.5% Triton X-100 for 5 min, then blocked twice using a mixture of 5% BSA and 10% goat serum for 30 min each. Samples were subsequently incubated with the primary antibodies to involucrin (Abcam, MA) at 1:100 for 45 min at room temperature and then with Alexa Fluor 488-conjugated secondary antibody (goat-anti-mouse antibody, dilution 1:500) (Life Technologies, CA) for 45 min in dark conditions at room temperature. Afterwards, the samples were incubated with the primary antibodies to ki-67 (Abcam, MA) at 1:100 for 45 min and subsequently with Alexa Fluor 594-conjugated secondary antibody (goat-anti-rabbit antibody, dilution 1:800) (Life Technologies, CA) for another 45 min. Cell nuclei were then counter-stained with DAPI for 5 min. All samples were imaged immediately without mounting. Visualization of samples was performed using a Nikon Eclipse Ti-S fluorescence microscope. Prior to immunostaining, the control of sectioned paraffin-embedded human skin samples was antigen retrieved by boiling the samples in 10 mM citrate buffer for 20 min at 120°C and cooled for 30 min at room temperature.
D. Barrier Function of Reconstructed Epidermis
i. Trans-epidermal Electrical Resistance
The electrical resistance of the reconstructed epidermis on hydrogels was directly measured using Agilent B2901A Precision Source/Measure Unit with 3V direct current voltage loading.[38] Plain hydrogel scaffolds were used as control.
ii. Permeability of Reconstructed Epidermis
To examine the permeability of reconstructed epidermis, cell inserts with or without (control) samples were placed inside a just fit PDMS mold (9.5 mm diameter and 5 mm depth) containing 200 μl DPBS. 200 μl of 1.25 mg/ml fluorescence labeled dextran solution (Cascade Blue, 10,000 MW, Anionic, Lysine Fixable, Life Technologies, NY) was then added on top of the sample. The mold was incubated at 37°C. At different time points (0.5, 1 and 2 h), 200 μl solutions from the PDMS mold was transferred into a 96 well plate and the quantity of dextran was measured using microplate reader (Bio-Tek, VT) at excitation wavelength of 360 nm and emission wavelength of 460 nm. Dextran standard curve was plotted as the fluorescence versus different dextran concentration at 0.001, 0.01, 0.1 and 1 mg mL−1. The percentage dextran permeability (Pwp) of the samples was determined using Equation (3):
(3) |
where Ct is the dextran concentration of samples calculated by comparison with the standard curves. M0 is the total amount of dextran used. Va (i.e., 200 μL) and Vb (i.e., 200 μL) are the volume of solution above and underneath the samples, respectively.
iii. Water Vapour Permeability of Reconstructed Epidermis
The water vapour permeability of the reconstructed epidermis on hydrogels was measured with the same setting used for dextran permeability measurement (cell inserts in PDMS mold). 200 μL of culture medium was added into the PDMS mold instead without the addition of medium on top of the sample. The mold was placed at 37°C for 24 h. The weight of the mold before and after incubation was recorded to determine the water loss from the samples.[57]
Statistical Analysis
All data were expressed as mean ± standard deviation (n=3). One-way ANOVA and Scheffe's post hoc test were used to determine statistical significance. p < 0.05 was considered significant.
Supplementary Material
Acknowledgements
We thank Drs Chong-Hyun Won and Nga Tran Thanh from Massachusetts General Hospital for the paraffin embedded human abdominal skin samples. The authors acknowledge funding from the National Science Foundation (EFRI-1240443), IMMODGEL (602694), and the National Institutes of Health (EB012597, AR057837, DE021468, HL099073, AI105024, AR063745).
Footnotes
Supporting Information
Supporting Information is available from the Wiley Online Library or from the author.
X. Z., Q. L. and L. Y. contributed equally to this work.
Contributor Information
Dr. Xin Zhao, Biomaterials Innovation Research Center, Division of Biomedical Engineering, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston 02139, MA, USA Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge 02139, MA, USA; Division of Immunology, School of Life Sciences, Faculty of Medicine and Health Sciences, Queen's Medical Centre, University of Nottingham, Nottingham NG7 2UH, United Kingdom.
Qi Lang, Biomaterials Innovation Research Center, Division of Biomedical Engineering, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston 02139, MA, USA; Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge 02139, MA, USA.
Dr. Lara Yildirimer, Biomaterials Innovation Research Center, Division of Biomedical Engineering, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston 02139, MA, USA Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge 02139, MA, USA.
Zhi Yuan (William) Lin, Biomaterials Innovation Research Center, Division of Biomedical Engineering, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston 02139, MA, USA; Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge 02139, MA, USA.
Prof. Wenguo Cui, Orthopedic Institute, Soochow University, 708 Renmin Rd, Suzhou, Jiangsu 215006, China
Dr. Nasim Annabi, Biomaterials Innovation Research Center, Division of Biomedical Engineering, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston 02139, MA, USA Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge 02139, MA, USA; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston 02115, MA, USA.
Prof. Kee Woei Ng, School of Materials Science and Engineering, Nanyang Technological University, N4.1 50 Nanyang Avenue, Singapore 639798, Singapore
Dr. Mehmet R. Dokmeci, Biomaterials Innovation Research Center, Division of Biomedical Engineering, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston 02139, MA, USA Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge 02139, MA, USA; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston 02115, MA, USA.
Prof. Amir M. Ghaemmaghami, Division of Immunology, School of Life Sciences, Faculty of Medicine and Health Sciences, Queen's Medical Centre, University of Nottingham, Nottingham NG7 2UH, United Kingdom
Prof. Ali Khademhosseini, Biomaterials Innovation Research Center, Division of Biomedical Engineering, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston 02139, MA, USA; Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge 02139, MA, USA; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston 02115, MA, USA; Department of Physics, King Abdulaziz University, Jeddah 21569, Saudi Arabia.
References
- 1.Braiman-Wiksman L, Solomonik I, Spira R, Tennenbaum Toxicol T. Pathol. 2007;35:767. doi: 10.1080/01926230701584189. [DOI] [PubMed] [Google Scholar]
- 2.Winter GD. Adv. Exp. Med. Biol. 1977;94:673. doi: 10.1007/978-1-4684-8890-6_92. [DOI] [PubMed] [Google Scholar]
- 3.Wagner JK, Parra EJ, Norton HL, Jovel C, Shriver MD. Pigm. Cell Res. 2002;15:385. doi: 10.1034/j.1600-0749.2002.02046.x. [DOI] [PubMed] [Google Scholar]
- 4.Shevchenko RV, James SL, James SE, Soc JR. Interface. 2010;7:229. doi: 10.1098/rsif.2009.0403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.MacNeil S. Nature. 2007;445:874. doi: 10.1038/nature05664. [DOI] [PubMed] [Google Scholar]
- 6.Trappmann B, Gautrot JE, Connelly JT, Strange DG, Li Y, Oyen ML, Cohen Stuart MA, Boehm Vogel V, Spatz JP, Watt FM, Huck WT. Nat. Mater. 2012;11:642. doi: 10.1038/nmat3339. [DOI] [PubMed] [Google Scholar]
- 7.Lee JE, Park JC, Hwang YS, Kim JK, Kim JG, Sub H. Yonsei Med. J. 2001;42:172. doi: 10.3349/ymj.2001.42.2.172. [DOI] [PubMed] [Google Scholar]
- 8.Silver FH, Freeman JW, DeVore D. Skin Res. Technol. 2001;7:18. doi: 10.1034/j.1600-0846.2001.007001018.x. [DOI] [PubMed] [Google Scholar]
- 9.Harding KG, Morris HL, Patel GK. BMJ. 2002;324:160. doi: 10.1136/bmj.324.7330.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Keriquel V, Guillemot F, Arnault I, Guillotin B, Miraux S, Amedee J, Fricain JC, Catros S. Biofabrication. 2010;2:014101. doi: 10.1088/1758-5082/2/1/014101. [DOI] [PubMed] [Google Scholar]
- 11.Ifkovits JL, Burdick JA. Tissue Eng. 2007;13:2369. doi: 10.1089/ten.2007.0093. [DOI] [PubMed] [Google Scholar]
- 12.Zhu J, Marchant RE. Expert Rev. Med. Devices. 2011;8:607. doi: 10.1586/erd.11.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.De Vuyst E, Charlier C, Giltaire S, De Glas V, de Rouvroit CL, Poumay Y. Methods Mol. Biol. 2014;1195:191. doi: 10.1007/7651_2013_40. [DOI] [PubMed] [Google Scholar]
- 14.Oh SA, Lee HY, Lee JH, Kim TH, Jang JH, Kim HW, Wall I. Tissue Eng. Pt. A. 2012;18:1087. doi: 10.1089/ten.TEA.2011.0360. [DOI] [PubMed] [Google Scholar]
- 15.Krishnan L, Weiss JA, Wessman MD, Hoying JB. Tissue Eng. 2004;10:241. doi: 10.1089/107632704322791880. [DOI] [PubMed] [Google Scholar]
- 16.Helary C, Abed A, Mosser G, Louedec L, Meddahi-Pelle A, Giraud-Guille MM. J. Tissue Eng. Regen. M. 2011;5:248. doi: 10.1002/term.326. [DOI] [PubMed] [Google Scholar]
- 17.Helary C, Bataille I, Abed A, Illoul C, Anglo A, Louedec L, Letourneur D, Meddahi-Pellé A, Giraud-Guille MM. Biomaterials. 2010;31:481. doi: 10.1016/j.biomaterials.2009.09.073. [DOI] [PubMed] [Google Scholar]
- 18.Hu K, Shi H, Zhu J, Deng D, Zhou G, Zhang W, Cao Y, Liu W. Biomed. Microdevices. 2010;12:627. doi: 10.1007/s10544-010-9415-4. [DOI] [PubMed] [Google Scholar]
- 19.Levis HJ, Brown RA, Daniels JT. Biomaterials. 2010;31:7726. doi: 10.1016/j.biomaterials.2010.07.012. [DOI] [PubMed] [Google Scholar]
- 20.Awang MA, Abu Bakar MF, Mh Busra MF, Roy Chowdhury S, Rajab NF, Wan Kamal WK, Reusmaazran MY, Aminuddin MY, Ruszymah BH. Biomed. Mater. Eng. 2014;24:1715. doi: 10.3233/BME-140983. [DOI] [PubMed] [Google Scholar]
- 21.Yeh MK, Liang YM, Cheng KM, Dai NT, Liu CC, Young JJ. Polymer. 2011;52:996. [Google Scholar]
- 22.Nichol JW, Koshy ST, Bae H, Hwang CM, Yamanlar S, Khademhosseini A. Biomaterials. 2010;31:5536. doi: 10.1016/j.biomaterials.2010.03.064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Bahney CS, Lujan TJ, Hsu CW, Bottlang M, West JL, Johnstone B. Eur. Cells Mater. 2011:22–43. doi: 10.22203/ecm.v022a04. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Chen YC, Lin RZ, Qi H, Yang Y, Bae H, Melero-Martin JM, Khademhosseini A. Adv. Funct. Mater. 2012;22:2027. doi: 10.1002/adfm.201101662. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Shin H, Olsen BD, Khademhosseini A. Biomaterials. 2012;33:3143. doi: 10.1016/j.biomaterials.2011.12.050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Salber J, Grater S, Harwardt M, Hofmann M, Klee D, Dujic J, Jinghuan H, Ding J, Kippenberger S, Bernd A, Groll J, Spatz JP, Möller M. Small. 2007;3:1023. doi: 10.1002/smll.200600596. [DOI] [PubMed] [Google Scholar]
- 27.Browning MB, Cereceres SN, Luong PT, Cosgriff-Hernandez EM. J. Biomed. Mater. Res. A. 2014;102:4244. doi: 10.1002/jbm.a.35096. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Lam J, Kim K, Lu S, Tabata Y, Scott DW, Mikos AG, Kasper FK. J. Biomed. Mater. Res. A. 2014;102:3477. doi: 10.1002/jbm.a.35015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Bourdoulous S, Orend G, MacKenna DA, Pasqualini R, Ruoslahti E. J. Cell Biol. 1998;143:267. doi: 10.1083/jcb.143.1.267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Chen CS, Mrksich M M, Huang S, Whitesides GM, Ingber DE. Science. 1997;276:1425. doi: 10.1126/science.276.5317.1425. [DOI] [PubMed] [Google Scholar]
- 31.Davey G, Buzzai M, Assoian RK. J. Cell Sci. 1999;112:4663. doi: 10.1242/jcs.112.24.4663. [DOI] [PubMed] [Google Scholar]
- 32.Huttenlocher A, Ginsberg MH, Horwitz AF. J. Cell Biol. 1996;134:1551. doi: 10.1083/jcb.134.6.1551. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Palecek SP, Loftus JC, Ginsberg MH, Lauffenburger DA, Horwitz AF. Nature. 1997;385:537. doi: 10.1038/385537a0. [DOI] [PubMed] [Google Scholar]
- 34.Boelsma E, Verhoeven MCH, Ponec M. J. Investig. Dermatol. 1999;112:489. doi: 10.1046/j.1523-1747.1999.00545.x. [DOI] [PubMed] [Google Scholar]
- 35.Schoop VM, Mirancea N, Fusenig NE. J. Investig. Dermatol. 1999;112:343. doi: 10.1046/j.1523-1747.1999.00524.x. [DOI] [PubMed] [Google Scholar]
- 36.Maas-Szabowski N, Starker A, Fusenig NE. J. Cell Sci. 2003;116:2937. doi: 10.1242/jcs.00474. [DOI] [PubMed] [Google Scholar]
- 37.Rheinwald JG, Green H. Cell. 1975;6:331. doi: 10.1016/s0092-8674(75)80001-8. [DOI] [PubMed] [Google Scholar]
- 38.Bernstam LI, Vaughan FL, Bernstein IA. In vitro Cell Dev. B. 1986;22:695. doi: 10.1007/BF02621086. [DOI] [PubMed] [Google Scholar]
- 39.Ponec M, Boelsma E, Weerheim A. Acta. Derm.-Venereol. 2000;80:89. [PubMed] [Google Scholar]
- 40.Peura M, Siltanen A, Saarinen I, Soots A, Bizik J, Vuola J, Harjula A, Kankuri E. J. Biomed. Mater. Res. A. 2010;95:658. doi: 10.1002/jbm.a.32881. [DOI] [PubMed] [Google Scholar]
- 41.Breitkreutz D, Schoop VM, Mirancea N, Baur M, Stark HJ, Fusenig NE. Eur. J. Cell Biol. 1998;75:273. doi: 10.1016/S0171-9335(98)80123-4. [DOI] [PubMed] [Google Scholar]
- 42.Brody I. J. investig. Dermatol. 1962;39:519. doi: 10.1038/jid.1962.151. [DOI] [PubMed] [Google Scholar]
- 43.Chau DY, Johnson C, MacNeil S, Haycock JW, Ghaemmaghami AM. Biofabrication. 2013;5:035011. doi: 10.1088/1758-5082/5/3/035011. [DOI] [PubMed] [Google Scholar]
- 44.Fowles DC, Schneider RE. Biol. Psychol. 1974;2:67. doi: 10.1016/0301-0511(74)90032-5. [DOI] [PubMed] [Google Scholar]
- 45.van der Valk P, van Kalken CK, Ketelaars H, Broxterman HJ, Scheffer G, Kuiper CM, Tsuruo T, Lankelma J, Meijer CJ, Pinedo HM, Scheper RJ. Ann. Oncol. 1990;1:56. [PubMed] [Google Scholar]
- 46.Narai A, Arai S, Shimizu M. Toxicol. In Vitro. 1997;11:347. doi: 10.1016/s0887-2333(97)00026-x. [DOI] [PubMed] [Google Scholar]
- 47.Mishra RK, Majeed ABA, Banthia AK. Int. J. Plast. Technol. 2011;15:82. [Google Scholar]
- 48.Balakrishnan B, Mohanty M, Umashankar PR, Jayakrishnan A. Biomaterials. 2005;26:6335. doi: 10.1016/j.biomaterials.2005.04.012. [DOI] [PubMed] [Google Scholar]
- 49.Cua AB, Wilhelm KP, Maibach HI. Br. J. Dermatol. 1990;123:473. doi: 10.1111/j.1365-2133.1990.tb01452.x. [DOI] [PubMed] [Google Scholar]
- 50.Fartasch M. Curr. Probl. Dermatol. 1995;23:95. doi: 10.1159/000424303. [DOI] [PubMed] [Google Scholar]
- 51.Hutson CB, Nichol JW, Aubin H, Bae H, Yamanlar S, Al-Haque S, Koshy ST, Khademhosseini A. Tissue Eng. Pt. A. 2011;17:1713. doi: 10.1089/ten.tea.2010.0666. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Poumay Y, Dupont F, Marcoux S, Leclercq-Smekens M, Herin M, Coquette A. Arch. Dermatol. Res. 2004;296:203. doi: 10.1007/s00403-004-0507-y. [DOI] [PubMed] [Google Scholar]
- 53.Jannasch M, Groeber F, Brattig NW, Unger C, Walles H, Hansmann J. Exp. Parasitol. 2015;150:22. doi: 10.1016/j.exppara.2015.01.005. [DOI] [PubMed] [Google Scholar]
- 54.Van Den Bulcke AI, Bogdanov B, De Rooze N, Schacht EH, Cornelissen M, Berghmans H. Biomacromolecules. 2000;1:31. doi: 10.1021/bm990017d. [DOI] [PubMed] [Google Scholar]
- 55.Xiao W, He J, Nichol JW, Wang L, Hutson CB, Wang B, Du Y, Fan H, Khademhosseini A. Acta Biomater. 2011;7:2384. doi: 10.1016/j.actbio.2011.01.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Ferreira L, Figueiredo MM, Gil MH, Ramos MA. J. Biomed. Mater. Res. B Appl. Biomater. 2006;77:55. doi: 10.1002/jbm.b.30394. [DOI] [PubMed] [Google Scholar]
- 57.Agren MS, Taplin CJ, Woessner JF, Eagistein WH, Mertz PM. J. Investig. Dermatol. 1992;99:709. doi: 10.1111/1523-1747.ep12614202. [DOI] [PubMed] [Google Scholar]
- 58.Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. J. Cell Biol. 1988;106:761. doi: 10.1083/jcb.106.3.761. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Shin H, Olsen BD, Khademhosseini A. Biomaterials. 2012;33:3143. doi: 10.1016/j.biomaterials.2011.12.050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Wu J, Zhao X, Wu D, Chu C-C. J. Mater. Chem. B. 2014;2:6660. doi: 10.1039/c4tb00576g. [DOI] [PubMed] [Google Scholar]
- 61.Canton I, Cole DM, Kemp EH, Watson PF, Chunthapong J, Ryan AJ, MacNeil S, Haycock JW. Biotechnol. Bioeng. 2010;106:794. doi: 10.1002/bit.22742. [DOI] [PubMed] [Google Scholar]
- 62.Haddow DB, France RM, Short RD, MacNeil S, Dawson RA, Leggett GJ, Cooper E. J. Biomed. Mater. Res. 1999;47:379. doi: 10.1002/(sici)1097-4636(19991205)47:3<379::aid-jbm13>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
- 63.Lerner LH, Qureshi AA, Reddy BV, Lerner EA. J. Investig. Dermatol. 2000;114:196. doi: 10.1046/j.1523-1747.2000.00816.x. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.